Showing 2321-2330 of 19322 results for "".
Measures to Improve Quality and Physician Payments
https://reachmd.com/programs/heart-matters/measures-to-improve-quality-and-physician-payments/3849/Host Dr. Jack Lewin speaks with Dr. James Dove, immediate past president of the American College of Cardiology, about strategies to improve the integration of quality into our healthcare system. No physician wants to fall short of providing the best care available, so it is imperative, Dr. Dove saysThe Importance of Non-HDL Cholesterol Testing
https://reachmd.com/programs/lipid-luminations/the-importance-of-non-hdl-cholesterol-testing/3705/Dr. Terry A. Jacobson explains to host Dr. Larry Kaskel the importance of non-HDL cholesterol reporting in lipid management. Dr. Jacobson describes additional lipid parameters that are emerging as valuable adjuncts to the standard panel, including measurements of apolipopprtoeins and LDL particle siPredictive Value of Lipid Biomarkers and Inflammatory Markers
https://reachmd.com/programs/lipid-luminations/predictive-value-of-lipid-biomarkers-and-inflammatory-markers/6296/Lipid Luminations host Dr. Alan Brown and his guest, Dr. Michael Davidson, discuss the predictive value of lipid biomarkers and inflammatory markers, particularly when compared with traditional risk factors, as well as the process of developing consensus on the use of novel risk factors. Brought toTreatments for Cardiac Blood Vessel Inflammation In the Works
https://reachmd.com/programs/clinicians-roundtable/treatments-for-cardiac-blood-vessel-inflammation-in-the-works/3659/Why aren't there medications to treat atherosclerosis or, more specifically, the underlying chronic inflammation of the blood vessel walls associated with this condition? Dr. Lawrence Cohen, president and CEO of VIA Pharmaceuticals, tells the Chicago Tribune's Bruce Japsen about the coming medicatioAnalysis of the Interheart Study
https://reachmd.com/programs/lipid-luminations/analysis-of-the-interheart-study/3579/The Interheart study identified nine easily measured factors that account for more than 90 percent of the risk of acute myocardial infarction, regardless of a patient's location, race or national origin. What are these factors, and how might they impact your practice? Host Dr. Larry KaskelBlood Matters: From Inherited Illness to Designer Babies
https://reachmd.com/programs/clinicians-roundtable/blood-matters-from-inherited-illness-to-designer-babies/2989/Blood Matters: From Inherited Illness to Designer Babies is the work of Moscow-based author and journalist, Masha Gessen. Ms. Gessen discusses her book, based in part upon her experience as a carrier of the BRCA gene, with host Dr. Michael Greenberg.Industry and Healthcare: Sorting Out Potential Conflicts
https://reachmd.com/programs/heart-matters/industry-and-healthcare-sorting-out-potential-conflicts/4045/How can individual practitioners interact with industry in a positive, lawful and commendable manner? Are there regulations we can and should put on companies in this arena which fund initiatives such as continuing medical education? Industry certainly plays a major role in health care today, but onATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
https://reachmd.com/programs/heart-matters/attr-cm-care-impact-of-vutrisiran-on-survival-and-cardiovascular-events/36144/Even though care for transthyretin amyloid cardiomyopathy (ATTR-CM) has advanced in recent years, this progressive disease is still associated with significant morbidity and mortality. That's why the HELIOS-B trial investigated vutrisiran, an RNA interference therapy, to determine its potential to rFactors Influencing the Selection of Amyloid PET Tests for Alzheimer Disease
https://reachmd.com/videos/neurology-in-motion/factors-influencing-the-selection-of-amyloid-pet-tests-for-alzheimer-disease/37135/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of amyloid PET tests for Alzheimer disease.Inherited Heart Diseases
https://reachmd.com/programs/clinicians-roundtable/inherited-heart-diseases/2523/How do we recognize and treat genetic heart disease in the single patient, and beyond? Dr. Elizabeth McNally, cardiologist and world-renowned expert on heart disease genetics speaks with Dr. Bruce Bloom on inherited heart diseases; covering their diagnosis, treatment, and varied prevalence around